CNTROB

Across TCGA pan-cancer cohorts, CNTROB mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CNTROB data layer compared with 21 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher CNTROB mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CNTROB expression acts as an unfavorable survival marker, although some lineages such as LUAD and GBM show a favorable association.

PDAC, LUAD, and GBM are the cancer types where CNTROB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Tertile	All	0.644	0.934	.002	35	view →
LUAD	DFS	Tertile	All	1.000	0.721	.037	3	view →
GBM	DFS	Quartile	All	0.385	0.243	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CNTROB–PDAC (DFS)

Open the PDAC breakdown →